Xconomy National

by in

Entry	Author	Date	Location
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors	Bruce V. Bigelow	04/27/11	San Diego
Genzyme-Sanofi Deal Might Be Close, Report Says	Ryan McBride	02/01/11	Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News	Erin Kutz	10/22/10	Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer	Ryan McBride	08/19/10	Boston
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News	Luke Timmerman	10/22/09	Seattle
Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants	Ryan McBride	05/27/09	San Diego
Riding a Cancer Diagnostics Wave, Genoptix Sees Boom Continuing in 2009	Luke Timmerman	04/01/09	San Diego
Trubion Cuts One-Fourth of Workforce	Luke Timmerman	02/25/09	Seattle
Merck Nabs Harvard Scientist To Replace Rosetta Founder as Oncology Research Head	Luke Timmerman	02/02/09	Boston
Seattle Genetics Drug Passes Safety Test, Trial Continues	Luke Timmerman	12/10/08	Seattle
Blood News: A Quick Rundown of Headlines From the American Society of Hematology	Luke Timmerman	12/09/08	National
Genzyme Asks FDA To Approve Drug for Acute Myeloid Leukemia	Luke Timmerman	11/24/08	Boston
Page 1 of 1